Cargando…
miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells
Patients with triple-negative breast cancers (TNBCs) typically have a poor prognosis. TNBCs are characterized by their resistance to apoptosis, aggressive cellular proliferation, migration and invasion, and currently lack molecular markers and effective targeted therapy. Recently, miR-221/miR-222 ha...
Autores principales: | Nassirpour, Rounak, Mehta, Pramod P., Baxi, Sangita M., Yin, Min-Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634767/ https://www.ncbi.nlm.nih.gov/pubmed/23637992 http://dx.doi.org/10.1371/journal.pone.0062170 |
Ejemplares similares
-
miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3
por: Nassirpour, Rounak, et al.
Publicado: (2013) -
Retraction: miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells
Publicado: (2017) -
Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells
por: Li, Shujun, et al.
Publicado: (2020) -
MiR-221 negatively regulates innate anti-viral response
por: Du, Hongqiang, et al.
Publicado: (2018) -
Expression of miR-221 and miR-489 in breast cancer patients and their relationship with prognosis
por: Li, Fanfan
Publicado: (2020)